Scott Filler, MD
Enriched profileProfessor-in-residence, Medicine · University of California, Los Angeles
Scott Filler is Professor-in-residence, Medicine at University of California, Los Angeles. OpenAlex indexes 299 publications with 27,893 citations (h-index 87); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Data verified 22 Oct 2026
Overview
Updated 23 Oct 2026
Scott Filler, M.D., is Professor-in-residence, Medicine at University of California, Los Angeles. The public record shows 299 publications with 27,893 citations (h-index 87), centered on Antifungal resistance and susceptibility, Fungal and yeast genetics research, Fungal Infections and Studies. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 5 companies, 13 NIH-funded awards (1990–2026).
- Most recent indexed publication: 2026 · mBio
- Top research focus: Antifungal resistance and susceptibility
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 50 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 231.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda
Sponsor: University of California, San Francisco
- A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Industry payments
Updated 23 Oct 2026
5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20253 payments
- Shionogi IncProgram year20253 payments
- Astellas Pharma US IncProgram year20251 payment
NIH funding
Updated 23 Oct 2026
13 NIH research awards on record, funded 1990–2026 per NIH RePORTER. The latest:
- Regulation of Candida albicans Pathogenesis by Protein Kinase and Transcription Factor Networks
University of Iowa
FY2026$762,744R01AI177254 - Epigenomic Mechanisms & STAT Networks in Persistent CA Candidemia
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2026$285,264U19AI172713 - Regulation of Candida albicans Pathogenesis by Protein Kinase and Transcription Factor Networks
University of Iowa
FY2025$739,862R01AI177254
Congress activity
Updated 23 Oct 2026
2 congress contributions (2020–2022) across AACR per OpenAlex. The most recent:
- Abstract 3044: C. albicans infection mediates upper gastrointestinal tract malignancy independently of Il17a in an APECED-like mouse model
AACR (meeting unresolved)
AACR2022Co-author - Abstract PR10: Candida albicans infection mediates gastrointestinal track malignancy independently of Il17a in an APECED mouse model
AACR Annual Meeting
AACR2020Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 23 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The HosA histone deacetylase regulates stress resistance, host cell interactions, and virulence in Aspergillus fumigatus.
Microbiology spectrum
Article2026 - Non-canonical IL‑22 receptor signaling remodels the oral mucosal barrier during Candida albicans immunosurveillance.
Nature communications
Article2026 - Non-viable Aspergillus fumigatus promotes chronic inflammation and angiogenesis in a murine fungus ball model.
Microbiology spectrum
Article2026 - Parasex generates highly recombinant progeny in Candida albicans with increased virulence.
Nature microbiology
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureusArticle1,467 citations2006
- 03Guidelines for Treatment of CandidiasisArticle1,445 citations2004
- 04Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasisArticle1,025 citations2009
- 05Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host CellsArticle639 citations2007
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 23 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/scott-filler-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
profiles.ucla.edu/scott.filler
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
Mentions by others
where others cite or feature them- Other
lundquist.org/news/2022-lundquist-legends-scott-filler-md-and-darrell-harrington-md-honored-for-their-outstanding-career-achievements
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lundquist.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lundquist.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗
Secondary affiliations
appointments beyond the home institution- Principal Investigator
The Lundquist Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lundquist.org ↗ - Former Chief
Division of Infectious Diseases, Harbor-UCLA Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lundquist.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Beth Karlan, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Jerome Engel, MD
University of California, Los Angeles
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital